Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVER-HOME: Anti-inflammatory Home-treatment for Early COVID-19
NCT05413642Phase 3Withdrawn
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jul 2023
- Primary completion
- Feb 2024
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Mario Negri Institute for Pharmacological Research. Primary endpoint: Proportion of patients who reach score ≥ 5 of MEWS at 90 days. Planned start Jul 2023; status: withdrawn.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05413642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05413642.